Eli Lilly (NYSE:LLY) recently announced several significant events, including promising trial results for baricitinib in ...

The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...

At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...

The drug shortages are the result of manufacturing problems, increased demand, and other issues. View on euronews ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

Robert F. Kennedy Jr. addressed the worsening avian flu crisis, saying vaccinating birds turns them into “mutation factories.

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...

The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.

The European Commission has proposed new rules aimed at strengthening the security of supply and availability of critical ...

Otsuka Pharmaceutical Europe and Lundbeck have announced that the European Commission has approved Rxulti (brexpiprazole) for ...